Wenjing Li

Wenjing Li is a highly experienced Senior Scientist currently at Bristol Myers Squibb since February 2022. Prior to this role, Wenjing held a similar position at Waters Corporation from January 2019 to February 2022, and completed a PhD in Pharmaceutical Sciences at the University of Maryland Baltimore, where studies focused on mass spectrometry, analytical chemistry, biochemistry, and retinoid metabolism. Additional experience includes a summer internship at Genentech in 2017 and a Master of Science in Pharmaceutical Sciences from Peking University from 2010 to 2013. Wenjing began academic training with a Bachelor of Science in Pharmaceutics from Shenyang Pharmaceutical University, earned in 2010.